Pulmatrix, Inc. (PULM) stock
PULMNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.37+0.04 (+3.01%)
Close on Nov 17, 2026Market cap $5.00MP/E –Yield –
Pulmatrix price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Pulmatrix's price to sales ratio was 3.1× on Apr 30, 2025, against 1.0× a year earlier. Over the last 5 years it ranged from 0.6× to 5.6×, with a median of 2.9×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2025 | Apr 30, 2025 | 3.1× | +0.5 |
| 2024 | Dec 31, 2024 | 2.5× | +1.5 |
| 2023 | Dec 29, 2023 | 1.0× | −1.9 |
| 2022 | Dec 30, 2022 | 2.9× | −0.7 |
| 2021 | Dec 31, 2021 | 3.7× | +0.3 |
| 2020 | Dec 31, 2020 | 3.3× | −29.8 |
| 2019 | Apr 30, 2019 | 33.1× | −40.5 |
| 2018 | Dec 31, 2018 | 73.6× | +24.6 |
| 2017 | Apr 28, 2017 | 49.1× | +40.3 |
| 2016 | Dec 30, 2016 | 8.8× | −166.5 |
| 2015 | Dec 31, 2015 | 175.3× | – |
See a number that looks wrong?